Bruce G. Allen Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6K Buy
74
+28
+61% +$10.4K 0.02% 358
2026
Q1
$13.5K Sell
46
-24
-34% -$7.89K 0.01% 449
2025
Q4
$24.5K Sell
70
-32
-31% -$10.8K 0.02% 368
2025
Q3
$33K Sell
102
-231
-69% -$71.8K 0.02% 328
2025
Q2
$130K Sell
333
-11
-3% -$4.42K 0.1% 119
2025
Q1
$150K Buy
344
+70
+26% +$28.1K 0.12% 100
2024
Q4
$101K Sell
274
-41
-13% -$17.2K 0.08% 141
2024
Q3
$164K Buy
315
+3
+1% +$1.6K 0.13% 102
2024
Q2
$169K Buy
312
+46
+17% +$24.3K 0.14% 86
2024
Q1
$138K Buy
266
+4
+2% +$1.99K 0.11% 115
2023
Q4
$124K Buy
+262
New +$121K 0.11% 120

Other funds holding ELV

Bruce G. Allen Investments's ELV Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Elevance Health (ELV) stake by 61% in Q2 2026, buying an estimated $10.4K and bringing the position to 74 shares worth $28.6K. The position accounts for 0.02% of the portfolio, ranked #358.

Bruce G. Allen Investments first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $169K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bruce G. Allen Investments held 74 shares of Elevance Health worth $28.6K as of Q2 2026.
  • Bruce G. Allen Investments bought 28 Elevance Health shares in Q2 2026, an estimated $10.4K.
  • Elevance Health made up 0.02% of Bruce G. Allen Investments's portfolio in Q2 2026, its #358 holding.
  • Bruce G. Allen Investments first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Elevance Health position peaked at $169K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.